Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
6.76
+0.55 (8.86%)
At close: May 3, 2024, 4:00 PM
6.50
-0.26 (-3.85%)
After-hours: May 3, 2024, 7:54 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 7,700 employees on December 31, 2023. The number of employees increased by 100 or 1.32% compared to the previous year.
Employees
7,700
Change (1Y)
100
Growth (1Y)
1.32%
Revenue / Employee
$310,858
Profits / Employee
-$10,908
Market Cap
2.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7,700 | 100 | 1.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
Dec 31, 2020 | 6,000 | 500 | 9.09% |
Dec 31, 2019 | 5,500 | -500 | -8.33% |
Dec 31, 2018 | 6,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Owens & Minor | 22,200 |
Evotec SE | 4,952 |
Tilray Brands | 1,600 |
Ginkgo Bioworks Holdings | 1,218 |
Galapagos NV | 1,123 |
Avadel Pharmaceuticals | 154 |
Structure Therapeutics | 93 |
AMRX News
- 11 hours ago - Drugmaker Amneal agrees to $270 million U.S. opioid settlement - Reuters
- 16 hours ago - Amneal Reports First Quarter 2024 Financial Results - Business Wire
- 3 days ago - California teams with Amneal Pharma for cheaper, generic version of Narcan - Market Watch
- 9 days ago - Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose - Business Wire
- 17 days ago - Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine - Business Wire
- 23 days ago - Amneal to Report First Quarter 2024 Results on May 3, 2024 - Business Wire
- 5 weeks ago - Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 - Business Wire
- 5 weeks ago - Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension - Business Wire